학술논문
40OBiomarker analyses of Asian women with hormone receptor-positive (HR+), HER2-negative (HER2–) advanced breast cancer (ABC) receiving ribociclib (RIB) + endocrine therapy (ET).
Document Type
Article
Author
Source
Subject
*HORMONE receptor positive breast cancer
*HORMONE therapy
*BREAST cancer
*HORMONES
*
*
*
Language
ISSN
0923-7534